| Dr Chelsea D Hutchison, PHARMD | |
|
10209 E Us Highway 36, Avon, IN 46123-7985 | |
| (317) 271-6598 | |
| (317) 735-3660 |
| Full Name | Dr Chelsea D Hutchison |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10209 E Us Highway 36, Avon, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962006205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26025845A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chelsea D Hutchison, PHARMD 10209 E Us Highway 36, Avon, IN 46123-7985 Ph: (317) 271-6598 | Dr Chelsea D Hutchison, PHARMD 10209 E Us Highway 36, Avon, IN 46123-7985 Ph: (317) 271-6598 |
News Archive
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
A BMJ investigation into the top-selling diabetes drug rosiglitazone (Avandia) raises concerns about its safety and the whole system by which drugs are evaluated, regulated, and promoted around the world.
A new patient survey can show improvements in the quality of patient decision-making about whether or not to undergo surgery for a herniated disc, reports a study in the August 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 3 days ago
Ms. Leslie Deann Wells, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 N Avon Ave, Avon, IN 46123 Phone: 317-272-2133 Fax: 317-272-5061 | |
Ms. Angela Marie Swiezy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7990 E Us Highway 36, Avon, IN 46123 Phone: 317-272-0242 | |
Julie Kippenbrock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7975 E Us Highway 36, Avon, IN 46123 Phone: 317-272-5563 | |
Dr. Beverly Rachel Bortz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 N Avon Ave, Avon, IN 46123 Phone: 317-272-2133 | |
David Errett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9500 E Us Highway 36, Avon, IN 46123 Phone: 317-209-8204 | |
Jillian Ashley Mcelmurry-dobin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7975 E Us Highway 36, Avon, IN 46123 Phone: 317-272-5563 Fax: 317-272-7061 | |
Mrs. Kara Anne Appell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10209 E Us Highway 36, Avon, IN 46123 Phone: 317-271-6598 |